INVESTORS & MEDIA

Dr. Coles has been a director of the company since 2017. He served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. from 2019 to 2023, and has served as chair of Cerevel Therapeutics Holdings, Inc. since 2018 and continues in this role.  He has also served as chair and chief executive officer of TRATE Enterprises LLC, a privately held company, since 2013. He is the former chief executive officer of Yumanity Therapeutics, Inc. Dr. Coles is also the former president, chief executive officer and chair of the board of Onyx Pharmaceuticals, Inc., and the former president, chief executive officer, and member of the board of directors of NPS Pharmaceuticals, Inc. He previously held various leadership positions in the biopharmaceutical and pharmaceutical industries, including at Merck & Co., Inc., Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated. In addition, he was a former director of Laboratory Corporation of America Holdings, Campus Crest Communities, Inc., CRISPR Therapeutics AG and McKesson Corporation.